Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Clinical Trials Artificial Intelligence Digital Health

ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials

  • News

Executive Summary

Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.

You may also be interested in...



ObvioHealth Is Ready For Decentralized Trials To Continue Growth Post-Pandemic

ObvioHealth is redefining clinical trials with its remote approach to address poor-quality patient-reported data and high costs while simultaneously discovering new trial outcomes.

Flywheel.io Raises $22M And Buys Out Competition

A series C funding round will enable Flywheel.io to buy out Radiologics and continue development of its clinical trial data management products.

Digital Health Roundup, April 2021: Digital Transformation In OR, Clinical Trials, Remote Monitoring

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from April.

Table

View full table

Related Content

Scrip

Topics

Tags:
Clinical Trials Artificial Intelligence Digital Health
Latest Headlines

Shattered Glass Or Broken Ladder: Is the Medtech Industry Becoming More Equal For Women?

FDA Leaves Global Harmonization Working Party, Will Focus International Harmonization Efforts Elsewhere

Solventum: The Identity Of 3M’s Health Care Spin-Off

Execs On The Move: October 2023

See All
UsernamePublicRestriction

Register

MT143811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By